Ranolazine hydrochloride is a prescription anti-anginal medication used to treat chronic angina (chest pain) by reducing the slow sodium current in heart muscle cells, which helps improve blood flow and reduce tension in the heart. It is grouped under the following drug class(es): Antianginals. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ranolazine dihydrochloride and Ranexa. Its PubChem CID is 71279.
Ranolazine hydrochloride
| CAS No | 95635-56-6 |
|---|---|
| Molecular Formula | C24H35Cl2N3O4 |
| Molecular Weight | 500.5 g/mol |
| Synonyms | N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ranolazine hydrochloride is a prescription anti-anginal medication used to treat chronic angina (chest pain) by reducing the slow sodium current in heart muscle cells, which helps improve blood flow and reduce tension in the heart.
The listed CAS number is 95635-56-6.
The listed molecular formula is C24H35Cl2N3O4.
The listed molecular weight is 500.5 g/mol.
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide;dihydrochloride.
The source lists Ranolazine dihydrochloride and Ranexa.